Malignant tumor and hyperfibrinogenemia.
- Author:
Xiuqiao LIU
1
;
Shujuan WANG
;
Zhenru WU
;
Wei SUN
;
Weihui WAN
Author Information
- Publication Type:Journal Article
- MeSH: Biomarkers, Tumor; metabolism; Female; Fibrinogen; metabolism; Humans; Male; Middle Aged; Neoplasms; blood; radiotherapy; Prognosis
- From: Chinese Journal of Oncology 2002;24(1):51-52
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo investigate the blood fibrinogen (FIB) content before and after chemotherapy or radiotherapy in 43 malignant tumor patients.
METHODSCOULTER ACL-200 automated coagulation analyzer was used in monitoring FIB in the patients.
RESULTSThe FIB content was significantly higher in malignant tumor patients than that in benign disease patients. Significant reduction was observed after treatment which became elevated again when there was recurrence or metastasis.
CONCLUSIONAssessment of FIB not only helps to diagnose cancers but evaluate the therapeutic effect and prognosis also.
